Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised to reshape virtual screening in early stage drug discovery and enhance ...

Turbine and AstraZeneca have entered a partnership to enhance the discovery of antibody-drug conjugates (ADCs) using the ...

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

Turbine, a leading company specializing in virtualizing biological experiments with AI, today announced a collaboration with ...

This year’s summit provides a platform for an outstanding group of researchers, evangelists and entrepreneurs to showcase the latest advances, applications and challenges regarding the deployment of ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry and AI to discover small molecule therapeutics for age-related diseases, ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development Virtual Event ...

Valinor’s academic collaborations with the Montgomery and Theis Labs will establish industry-standard benchmarks for assessing the clinical translatability of perturbation prediction models Valinor ...